Quattro Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$602K Hold
25,000
0.13% 78
2026
Q1
$702K Sell
25,000
-25,000
-50% -$666K 0.21% 67
2025
Q4
$1.25M Sell
50,000
-800
-2% -$20.2K 0.37% 47
2025
Q3
$1.29M Buy
50,800
+800
+2% +$19.7K 0.41% 44
2025
Q2
$1.21M Sell
50,000
-25,000
-33% -$583K 0.43% 48
2025
Q1
$1.9M Sell
75,000
-95,781
-56% -$2.51M 0.65% 42
2024
Q4
$4.51M Buy
170,781
+10,517
+7% +$285K 1.17% 22
2024
Q3
$4.64M Buy
160,264
+40,264
+34% +$1.17M 1.31% 23
2024
Q2
$3.36M Buy
120,000
+25,000
+26% +$688K 0.88% 27
2024
Q1
$2.64M Buy
95,000
+94,971
+327,486% +$2.64M 0.75% 29
2023
Q4
$2.74M Sell
29
-59,971
-100% -$1.81M 0.95% 26
2023
Q3
$1.99M Buy
+60,000
New +$2.12M 0.87% 32
2020
Q1
Sell
-8,854
Closed -$337K 56
2019
Q4
$337K Sell
8,854
-2,160
-20% -$76.9K 0.11% 45
2019
Q3
$373K Buy
+11,014
New +$401K 0.11% 47

Other funds holding PFE

Quattro Financial Advisors's PFE Position: Q2 2026 in Review

Quattro Financial Advisors held its Pfizer (PFE) position steady in Q2 2026 at 25,000 shares worth $602K. The position accounts for 0.13% of the portfolio, ranked #78.

Quattro Financial Advisors first reported a position in PFE in Q3 2019 and has held it in 14 quarters since. The position peaked at $4.64M in Q3 2024. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Quattro Financial Advisors held 25,000 shares of Pfizer worth $602K as of Q2 2026.
  • Quattro Financial Advisors left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.13% of Quattro Financial Advisors's portfolio in Q2 2026, its #78 holding.
  • Quattro Financial Advisors first reported a position in Pfizer in Q3 2019 and has held it in 14 quarters since.
  • Quattro Financial Advisors's Pfizer position peaked at $4.64M in Q3 2024.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Quattro Financial Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.